CAS: 1262618-39-2 - GS967
![1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-](https://static.cymitquimica.com/products/IN/thumb/DA000SFD.jpg)
1,2,4-Triazolo[4,3-a]pyridine, 6-[4-(trifluoromethoxy)phenyl]-3-(trifluoromethyl)-
CAS:1262618-39-2
Formula:
C14H7F6N3O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
347.2153
Ref: IN-DA000SFD
| 10mg | 75.00 € | ||
| 25mg | 117.00 € | ||
| 50mg | 198.00 € | ||
| 100mg | 220.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
GS967
CAS:1262618-39-2
GS967 is a potent, and selective inhibitor of cardiac late sodium current (late INa ).
Formula:
C14H7F6N3O
Purity:
100% - 99.62%
Color and Shape:
Solid
Molecular weight:
347.22
Ref: TM-T2049
| 2mg | 35.00 € | ||
| 5mg | 52.00 € | ||
| 10mg | 78.00 € | ||
| 25mg | 158.00 € | ||
| 50mg | 280.00 € | ||
| 100mg | 490.00 € | ||
| 200mg | 709.00 € | ||
| 500mg | 1,093.00 € | ||
| 1mL*10mM (DMSO) | 58.00 € |
Estimated delivery in United States, on Wednesday 29 Jan 2025
GS 967
CAS:1262618-39-2
Inhibits cardiac late sodium channel current; antiarrhythmic
Formula:
C14H7F6N3O
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
347.22 g/mol
Ref: 3D-FT65033
| 10mg | 270.00 € | ||
| 50mg | 753.00 € |
Estimated delivery in United States, on Tuesday 4 Feb 2025
